Skip to main content

Table 1 Baseline clinical characteristics (n = 97)

From: Venous thromboembolism in hospitalized patients receiving chemotherapy for malignancies at Japanese community hospital: prospective observational study

Characteristic No. of patients (%)
Age (yr.) 65 ±12.1a
Sex ratio (M:F) 47 :50
Body mass index (kg/m2) 22 ± 3.4a
Reduced mobilityc 10 10
Previous chemotherapy 19 20
Time from tumor onset (yr.) 3 (1–12)b
Using anti-VGEF antibody 17 18
Recent (≤1 month) surgery 6 6
Recent (≤1 month) radiation 3 3
Complication
 Rheumatic arthritis 3 3
 Chronic heart failure 1 1
Tumor type
Digestive cancer
 Colon or rectum 26 27
 Stomach 18 19
 Esophagus 6 6
 Pancreas 7 7
 Otherd 2 2
Female reproductive system cancer
 Breast 22 23
 Ovary 3 3
Other tumor
 Lung cancer 2 2
 Urinary tract cancer 2 2
 Urachus cancer 1 1
 Cancer of unknown primary 4 4
 Sarcomae 3 3
 Lymphoma 1 1
Distant metastases 65 67
  1. VEGF vascular endothelial cell growth factor
  2. aMean ± standard deviation. bMedian (interquartile range). cBedrest with bathroom privileges for at least three days, either due to patient’s limitation or on physician’s order. dLiver and biliary tract. ethymus and prostate.